Bad blood : secrets and lies in a Silicon Valley startup
(Book)

Book Cover
Average Rating
Published
New York : Alfred A. Knopf, 2018.
Edition
First edition.
Physical Desc
x, 339 pages ; 25 cm
Status
PCPLS - Hebron Public Library - Adult Nonfiction
338.76817 CARRE
1 available
PCPLS - Kouts Public Library - Adult Nonfiction
338.76817 CARRE
1 available
PCPLS - Portage Public Library - Adult Nonfiction
338.76817 CARRE
1 available

Description

Loading Description...

Copies

LocationCall NumberStatus
PCPLS - Hebron Public Library - Adult Nonfiction338.76817 CARREOn Shelf
PCPLS - Kouts Public Library - Adult Nonfiction338.76817 CARREOn Shelf
PCPLS - Portage Public Library - Adult Nonfiction338.76817 CARREOn Shelf
LocationCall NumberStatus
Adams PL Sys. - Decatur Branch - Adult Non-Fiction338.7 CAR BADOn Shelf
Batesville Mem. PL - Batesville - Non-Fiction 300-399338.7 CARREYROUOn Shelf
Benton Co PL - Fowler - Adult Nonfiction338.7 CAROn Shelf
Brazil PL - Brazil - Second Floor, Non-Fiction338.7 COn Shelf
Clinton PL - Clinton - NON-FICTION 2ND FLOOR338.7681 CAROn Shelf
Show All Copies

Also in this Series

Checking series information...

More Like This

Loading more titles like this title...

Other Editions and Formats

More Details

Published
New York : Alfred A. Knopf, 2018.
Format
Book
Edition
First edition.
Language
English
UPC
99977268312, 40028196876

Notes

Bibliography
Includes bibliographical references (pages 305-324) and index.
Description
In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: the technology didn't work. For years, Holmes had been misleading investors, FDA officials, and her own employees. When the author, working at The Wall Street Journal, got a tip from a former Theranos employee and started asking questions, both the author and the newspaper were threatened with lawsuits. Undaunted, the paper ran the first of dozens of Theranos articles in late 2015. By early 2017, the company's value was zero and Holmes faced potential legal action from the government and her investors. The biggest corporate fraud since Enron is a cautionary tale set amid the bold promises and gold-rush frenzy of Silicon Valley. --,Publisher information.

Reviews from GoodReads

Loading GoodReads Reviews.

Citations

APA Citation, 7th Edition (style guide)

Carreyrou, J. (2018). Bad blood: secrets and lies in a Silicon Valley startup (First edition.). Alfred A. Knopf.

Chicago / Turabian - Author Date Citation, 17th Edition (style guide)

Carreyrou, John. 2018. Bad Blood: Secrets and Lies in a Silicon Valley Startup. Alfred A. Knopf.

Chicago / Turabian - Humanities (Notes and Bibliography) Citation, 17th Edition (style guide)

Carreyrou, John. Bad Blood: Secrets and Lies in a Silicon Valley Startup Alfred A. Knopf, 2018.

MLA Citation, 9th Edition (style guide)

Carreyrou, John. Bad Blood: Secrets and Lies in a Silicon Valley Startup First edition., Alfred A. Knopf, 2018.

Note! Citations contain only title, author, edition, publisher, and year published. Citations should be used as a guideline and should be double checked for accuracy. Citation formats are based on standards as of August 2021.

Staff View

Loading Staff View.